Despite popular belief, the biotechnology and biopharmaceutical industry suffered immense losses as a result of the COVID-19 pandemic. As many hospitals have surpassed maximum capacity, clinical trials that cost billions of dollars had to be paused or even stopped.
Biotechnology In the Time of COVID-19: Past, Present, and Future
